Insider · CIK 0002092283
Slanix Paul Alex
Files at PMN (ProMIS Neurosciences Inc.). First filing Feb 5, 2026, latest Feb 5, 2026.
In brief
Slanix Paul Alex files SEC Form 4 as director at PMN (ProMIS Neurosciences Inc.). Since Feb 5, 2026, Slanix Paul Alex has reported 1 open-market buy worth $8.5M and 0 open-market sells worth $0, the latest filed on Feb 5, 2026.
A track record needs three past buys with six months of prices behind them; Slanix Paul Alex has 0, so none is measured yet.
The newest scored trade: bought $8.5M of PMN on Feb 3, 2026, filed Feb 5, 2026, scored 58 (moderate). In the last 12 months: 1 buy worth $8.5M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PMN: ProMIS Neurosciences Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | PMNbuy ProMIS Neurosciences Inc. | $8.5M 700,741 shares | +289% | +135% from low-43% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +5,500 | $0.00 | $0 | 5,500 | May 22, 2026 |
| May 20, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +11,000 | $0.00 | $0 | 11,000 | May 22, 2026 |
| Feb 3, 2026 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Common Sharesindirect: See Footnote | +700,741 | $12.13 | $8.5M | 943,090 | Feb 5, 2026 |
| Feb 3, 2026 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Warrantsderivativeindirect: See Footnote | +700,741 | - | - | 700,741 | Feb 5, 2026 |
| Oct 22, 2025 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Oct 24, 2025 |
Questions about Slanix Paul Alex
Answered from the filings on this page, as of the latest one.
Is Slanix Paul Alex buying or selling?
In the last 12 months Slanix Paul Alex reported 1 open-market buy worth $8.5M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $8.5M of PMN on Feb 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Slanix Paul Alex's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Slanix Paul Alex has 0.
Where does Slanix Paul Alex file Form 4?
Slanix Paul Alex has filed Form 4 at PMN (ProMIS Neurosciences Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.